No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2
Saved in:
| Main Authors: | Shan-Lu Liu, Linda J. Saif, Susan R. Weiss, Lishan Su |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-01-01
|
| Series: | Emerging Microbes and Infections |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1733440 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
One Health perspectives on SARS-CoV-2 and other coronavirus threats to humans and animals
by: Linda J. Saif
Published: (2025-06-01) -
Bühlmann's Credibility Model with Claims of Negative Binomial and 2-Poisson Distribution
by: Ikhsan Maulidi, et al.
Published: (2023-05-01) -
Restraining SARS-CoV-2 in histopathology laboratory amid COVID-19 pandemic
by: Efosa Bolaji Odigie, et al.
Published: (2022-01-01) -
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01) -
An elusive debate on the evidence for RNA editing in SARS-CoV-2
by: Giorgio Mattiuz, et al.
Published: (2024-12-01)